Skip to content
Brain section no propranolol

Image -

Brain section no propranolol

Propranolol treatment contributes to reduced number and size of cerebral cavernous malformations. Panel A shows a brain section of vehicle treated mouse. The lesions are outlined in green.
Joppe Oldenburg
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By:
Joppe Oldenburg
File format:
.jpg
Size:
4688 x 2867, 17.8 MB
Download

Contacts

Related content

  • Propranolol treatment contributes to reduced number and size of cerebral cavernous malformations. The lesions are outlined in green. Photo: Joppe Oldenburg

    Beta blockers can repair malformed blood vessels in the brain

    Propranolol, a drug that is efficacious against infantile haemangiomas (“strawberry naevi”, resembling birthmarks), can also be used to treat cerebral cavernous malformations, a condition characterised by misshapen blood vessels in the brain and elsewhere. This has been shown by researchers at Uppsala University in a new study published in the scientific journal Stroke.